BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29063720)

  • 1. Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans.
    Lee HS; Lee SB; Kim BM; Hong M; Jung S; Hong J; Baek J; Han B; Oh SH; Kim KM; Park SH; Yang SK; Ye BD; Song K
    J Gastroenterol Hepatol; 2018 Apr; 33(4):887-893. PubMed ID: 29063720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.
    Lin X; Yan C; Gao Y; Du J; Zhu X; Yu F; Huang T; Dai J; Ma H; Jiang Y; Yin R; Hu Z; Jin G; Xu L; Shen H
    Cancer Sci; 2017 Feb; 108(2):250-255. PubMed ID: 27960044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men.
    Akinyemi R; Arnett DK; Tiwari HK; Ovbiagele B; Sarfo F; Srinivasasainagendra V; Irvin MR; Adeoye A; Perry RT; Akpalu A; Jenkins C; Owolabi L; Obiako R; Wahab K; Sanya E; Komolafe M; Fawale M; Adebayo P; Osaigbovo G; Sunmonu T; Olowoyo P; Chukwuonye I; Obiabo Y; Akpa O; Melikam S; Saulson R; Kalaria R; Ogunniyi A; Owolabi M;
    J Neurol Sci; 2017 Aug; 379():229-235. PubMed ID: 28716248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
    Duesing K; Fatemifar G; Charpentier G; Marre M; Tichet J; Hercberg S; Balkau B; Froguel P; Gibson F
    Diabetologia; 2008 May; 51(5):821-6. PubMed ID: 18368387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A
    PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.
    Youn BJ; Cheong HS; Namgoong S; Kim LH; Baek IK; Kim JH; Yoon SJ; Kim EH; Kim SH; Chang JH; Kim SH; Shin HD
    Mol Biol Rep; 2022 Nov; 49(11):10339-10346. PubMed ID: 36097105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma.
    Osman W; Low SK; Takahashi A; Kubo M; Nakamura Y
    Hum Mol Genet; 2012 Jun; 21(12):2836-42. PubMed ID: 22419738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
    Hannou SA; Wouters K; Paumelle R; Staels B
    Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study.
    Jung S; Ye BD; Lee HS; Baek J; Kim G; Park D; Park SH; Yang SK; Han B; Liu J; Song K
    J Crohns Colitis; 2021 Nov; 15(11):1898-1907. PubMed ID: 33853113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.
    Wang W; Oh S; Koester M; Abramowicz S; Wang N; Tall AR; Welch CL
    Circ Cardiovasc Genet; 2016 Jun; 9(3):213-22. PubMed ID: 27098250
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
    Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the functional role of polymorphism in the CDKN2B-AS1 gene GWAS-significant for primary open-angle glaucoma (an in-silico study)].
    Eliseeva NV; Ponomarenko IV; Churnosov MI
    Vestn Oftalmol; 2021; 137(4):43-50. PubMed ID: 34410056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
    Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
    Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
    Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
    Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 9p21 primary open-angle glaucoma susceptibility locus: a review.
    Ng SK; Casson RJ; Burdon KP; Craig JE
    Clin Exp Ophthalmol; 2014; 42(1):25-32. PubMed ID: 24112133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
    Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
    BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.
    Iolascon A; Giordani L; Moretti A; Tonini GP; Lo Cunsolo C; Mastropietro S; Borriello A; Ragione FD
    Pediatr Res; 1998 Jan; 43(1):139-44. PubMed ID: 9432125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
    Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
    Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.